Asia-Pacific Foot and Ankle Allografts Market, By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, and Amniotic Membranes), Surgery Type (Orthopedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon & Ligament Repair, and Wound Care), Procedure (Midfoot Procedures and Hindfoot Procedures), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres, Academic and Research Institutes, and Other End Users) – Industry Trends and Forecast to 2029.
Asia-Pacific Foot and Ankle Allograft Market Analysis and Insights
Rising prevalence of orthopaedic diseases and foot and ankle disorders, along with the increase in continuous product commercialization and rising geriatric population; are the major drivers which propelled the demand of the market in the forecast period.
High costs associated with foot and ankle allograft devices and lack of formal education and training may hamper the future growth of Asia-Pacific foot and ankle allografts market. The partnerships and acquisitions by major market players act as opportunity for the growth of foot and ankle allografts market.
Asia-Pacific foot and ankle allografts market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.0% in the forecast period of 2022 to 2029 and is expected to reach USD 256.59 million by 2029 from USD 135.71 million in 2021.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2015-2019)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, and Amniotic Membranes), Surgery Type (Orthopaedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon & Ligament Repair, and Wound Care), Procedure (Midfoot Procedures and Hindfoot Procedures), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres, Academic and Research Institutes, and Other End Users)
|
|
Countries Covered
|
China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific
|
|
Market Players Covered
|
LifeNet Health (U.S.), Zimmer Biomet (U.S.), Johnson and Johnson services Inc (U.S.), Integra LifeSciences (U.S.), CONMED Corporation. (U.S.), Stryker (U.S.), Globus Medical (U.S.), Smith –Nephew (U.S.), Institut Straumann AG (Switzerland), Arthrex, Inc. (Germany), Organogenesis Inc. (U.S.)
|
Market Definition
Foot and ankle allografts is a technique used in a number of medical procedures to save lives, repair limbs, and relieve pain in the patient by transplanting a cell or a tissue from one person to another. The donor should be non-identical, of the same species but of a different genotype. Allografts are used for various treatment and procedures such as orthopedic reconstruction, cartilage restoration, soft tissue tendon & ligament repair and wound care. Allografts are most commonly used in reconstructive surgeries around the foot and ankle. Compared to autograft tissue, allografts provide advantages such as less operative time, unlimited tissue sources, and lack of potential donors-site morbidity.
Asia-Pacific Foot and Ankle Allografts Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Growing Geriatric Population
Geriatric population are more prone to the conditions leading to fragile bones and joints. In such patients allografts are used in the procedure to provide them immediate and efficient benefits associated with their body.
- Increase in Prevalence of Musculoskeletal Disorder
Musculoskeletal disorders comprises of fractures associated with bone fragility, osteoarthritis, injuries and systemic inflammatory conditions such as rheumatoid arthritis. Allografts have been used to correct these deformities or to fill bone defects secondary to trauma, osteochondral lesions, or intercalary arthrodesis.
Restrain
-
Stringent Regulatory
The allografts are regulated by a structure of laws, rules, and regulations that are extensive and complex to safeguard them from use in any potential harmful treatment. The need for more stringent privacy policies and regulations has limited the growth of this market
Opportunity
- Increasing Reimbursement Policies
Increasing Universal Health Coverage (UHC) is widely believed to drive better patient accessibility to healthcare systems. Moreover, a number of organizations have initiated reimbursement policies. The policies programs help in covering healthcare needs of population are expected to create a significant opportunity for the market.
Challenge
- Lack of Awareness for Foot and Ankle Solutions
A large number of population suffers from foot and ankle cases in underdeveloped countries. These cases tend to get neglected or mismanaged, as ankle orthopedics has yet to establish itself as the specialty of orthopedics in developing countries. Moreover, lack of knowledge about the availability of foot and ankle solutions in society as well as in medical population pose as a major challenge for the market.
Recent Developments
- In March 2022, Lifenet Health announce that they will be showcasing their innovative all-human research solutions at SOT ToxExpo which has increased company’s customer’s engagement.
- In March 2022, Zimmer Biomet announced that they have sign a multiyear agreement with Biocomposites to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market. This will help company to increase their revenue and sales.
- In August 2021, Johnson & Johnson Services Inc., announced that their company DePuy Synthes has featured their new products and technology solutions shaping new standards of care for modern day orthopaedics during the American Academy of Orthopaedic Surgeons (AAOS) annual meeting. This has helped the company to gain more customers and sales.
Asia-Pacific Foot and Ankle Allografts Market Scope
Asia-Pacific foot and ankle allografts market is segmented on the basis of product type, surgery type, procedure and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- Allograft Wedges
- Allograft Tendons
- Allograft Acellular Dermal Matrix
- Cartilage Allograft Matrix
- Skin Allografts
- Amniotic Membranes
On the basis of product type, the market is segmented into allograft wedges, allograft tendons, allograft acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes.
Surgery Type
- Orthopaedic Reconstruction
- Cartilage Restoration
- Soft Tissue Tendon and Ligament Repair
- Wound Care
On the basis of surgery type, the market is segmented into orthopaedic reconstruction, cartilage restoration, soft tissue tendon and ligament repair, and wound care.
Procedure
- Midfoot Procedures
- Hindfoot Procedures
On the basis of procedure, the market is segmented into midfoot procedures and hindfoot procedures.
End User
- Hospitals
- Orthopaedic Clinics
- Ambulatory Surgical Centres
- Academic and Research Institutes
- Other End Users
On the basis of end user, the market is segmented into hospital, orthopaedic clinics, ambulatory surgical centres, academic and research institutes, and other end users.
Asia-Pacific Foot and Ankle Allografts Market Country Level Analysis
The foot and ankle allografts market is analyzed and market size information is provided by product type, surgery type, procedure and end user.
The countries covered in the Asia-Pacific foot and ankle allograft market report are the China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.
China is expected to dominate the market due to the increasing geriatric population and is expected to grow due to rise in continuous product commercialization.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Foot and Ankle Allografts Market Share Analysis
Foot and ankle allografts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the foot and ankle allografts market.
The major companies which are dealing in the foot and ankle allografts market are LifeNet Health (U.S.), Zimmer Biomet (U.S.), Johnson and Johnson services Inc (U.S.), Integra LifeSciences (U.S.), CONMED Corporation. (U.S.), among others.
SKU-